http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Tue, 19 May 2026 16:45:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Press+Releases/Journey+Medical+Corporation+to+Participate+in+A.G.P.%E2%80%99s+Annual+Virtual+Healthcare+Conference/26522100.html <p align="justify">SCOTTSDALE, Ariz., May 19, 2026 (GLOBE NEWSWIRE) -- Journey Medical Corporation (Nasdaq: DERM) (“Journey Medical,” “the Company,” “we” or “our”), a commercial-stage pharmaceutical company focused on developing, selling and marketing FDA-approved prescription pharmaceutical products for the treatment of dermatological conditions, today announced that Claude Maraoui, Co-Founder, President and Chief Executive Officer, will participate in a fireside chat at A.G.P.’s Annual Virtual Healthcare Conference, taking place on Wednesday, May 20, 2026. The fireside chat is scheduled to begin at 5:00pm ET.</p> <p align="justify">To register for the conference, visit the <a href="https://www.globenewswire.com/Tracker?data=OOnUQrpGBOdiZA_ykhEnctREvewm_M_zeH5lgXKPTJ6PdAQhDS8guIMzgc_NnIbUMRt3gX6hHHphHejGuMSpIKyvPml9N5rcL7IRjAkmbyYYd3Qse30RWlLCqWbLG7kdTCVU5HstVwDGMjZOp1ithQoGQYWJi8EFlO9W4oFM5l593bnQ6QOR3xpef6LhlwqY" rel="nofollow" target="_blank"><u>A.G.P. Registration Link</u></a>.</p> <p http://www.streetinsider.com/Press+Releases/Journey+Medical+Corporation+to+Participate+in+A.G.P.%E2%80%99s+Annual+Virtual+Healthcare+Conference/26522100.html Tue, 19 May 2026 16:45:00 -0400 DERM DERM FBIO http://www.streetinsider.com/Press+Releases/Journey+Medical+Corporation+to+Participate+in+A.G.P.%E2%80%99s+Annual+Virtual+Healthcare+Conference/26522100.html <p align="justify">SCOTTSDALE, Ariz., May 19, 2026 (GLOBE NEWSWIRE) -- Journey Medical Corporation (Nasdaq: DERM) (“Journey Medical,” “the Company,” “we” or “our”), a commercial-stage pharmaceutical company focused on developing, selling and marketing FDA-approved prescription pharmaceutical products for the treatment of dermatological conditions, today announced that Claude Maraoui, Co-Founder, President and Chief Executive Officer, will participate in a fireside chat at A.G.P.’s Annual Virtual Healthcare Conference, taking place on Wednesday, May 20, 2026. The fireside chat is scheduled to begin at 5:00pm ET.</p> <p align="justify">To register for the conference, visit the <a href="https://www.globenewswire.com/Tracker?data=OOnUQrpGBOdiZA_ykhEnctREvewm_M_zeH5lgXKPTJ6PdAQhDS8guIMzgc_NnIbUMRt3gX6hHHphHejGuMSpIKyvPml9N5rcL7IRjAkmbyYYd3Qse30RWlLCqWbLG7kdTCVU5HstVwDGMjZOp1ithQoGQYWJi8EFlO9W4oFM5l593bnQ6QOR3xpef6LhlwqY" rel="nofollow" target="_blank"><u>A.G.P. Registration Link</u></a>.</p> <p http://www.streetinsider.com/Press+Releases/Journey+Medical+Corporation+to+Participate+in+A.G.P.%E2%80%99s+Annual+Virtual+Healthcare+Conference/26522100.html Tue, 19 May 2026 16:45:00 -0400 DERM DERM FBIO http://www.streetinsider.com/Press+Releases/Journey+Medical+Corporation+to+Participate+in+A.G.P.%E2%80%99s+Annual+Virtual+Healthcare+Conference/26522100.html <p align="justify">SCOTTSDALE, Ariz., May 19, 2026 (GLOBE NEWSWIRE) -- Journey Medical Corporation (Nasdaq: DERM) (“Journey Medical,” “the Company,” “we” or “our”), a commercial-stage pharmaceutical company focused on developing, selling and marketing FDA-approved prescription pharmaceutical products for the treatment of dermatological conditions, today announced that Claude Maraoui, Co-Founder, President and Chief Executive Officer, will participate in a fireside chat at A.G.P.’s Annual Virtual Healthcare Conference, taking place on Wednesday, May 20, 2026. The fireside chat is scheduled to begin at 5:00pm ET.</p> <p align="justify">To register for the conference, visit the <a href="https://www.globenewswire.com/Tracker?data=OOnUQrpGBOdiZA_ykhEnctREvewm_M_zeH5lgXKPTJ6PdAQhDS8guIMzgc_NnIbUMRt3gX6hHHphHejGuMSpIKyvPml9N5rcL7IRjAkmbyYYd3Qse30RWlLCqWbLG7kdTCVU5HstVwDGMjZOp1ithQoGQYWJi8EFlO9W4oFM5l593bnQ6QOR3xpef6LhlwqY" rel="nofollow" target="_blank"><u>A.G.P. Registration Link</u></a>.</p> <p http://www.streetinsider.com/Press+Releases/Journey+Medical+Corporation+to+Participate+in+A.G.P.%E2%80%99s+Annual+Virtual+Healthcare+Conference/26522100.html Tue, 19 May 2026 16:45:00 -0400 DERM DERM FBIO http://www.streetinsider.com/Globe+Newswire/Journey+Medical+Corporation+to+Participate+in+A.G.P.%E2%80%99s+Annual+Virtual+Healthcare+Conference/26522100.html <p align="justify">SCOTTSDALE, Ariz., May 19, 2026 (GLOBE NEWSWIRE) -- Journey Medical Corporation (Nasdaq: DERM) (“Journey Medical,” “the Company,” “we” or “our”), a commercial-stage pharmaceutical company focused on developing, selling and marketing FDA-approved prescription pharmaceutical products for the treatment of dermatological conditions, today announced that Claude Maraoui, Co-Founder, President and Chief Executive Officer, will participate in a fireside chat at A.G.P.’s Annual Virtual Healthcare Conference, taking place on Wednesday, May 20, 2026. The fireside chat is scheduled to begin at 5:00pm ET.</p> <p align="justify">To register for the conference, visit the <a href="https://www.globenewswire.com/Tracker?data=OOnUQrpGBOdiZA_ykhEnctREvewm_M_zeH5lgXKPTJ6PdAQhDS8guIMzgc_NnIbUMRt3gX6hHHphHejGuMSpIKyvPml9N5rcL7IRjAkmbyYYd3Qse30RWlLCqWbLG7kdTCVU5HstVwDGMjZOp1ithQoGQYWJi8EFlO9W4oFM5l593bnQ6QOR3xpef6LhlwqY" rel="nofollow" target="_blank"><u>A.G.P. Registration Link</u></a>.</p> <p http://www.streetinsider.com/Globe+Newswire/Journey+Medical+Corporation+to+Participate+in+A.G.P.%E2%80%99s+Annual+Virtual+Healthcare+Conference/26522100.html Tue, 19 May 2026 16:45:00 -0400 DERM DERM FBIO http://www.streetinsider.com/Globe+Newswire/Journey+Medical+Corporation+to+Participate+in+A.G.P.%E2%80%99s+Annual+Virtual+Healthcare+Conference/26522100.html <p align="justify">SCOTTSDALE, Ariz., May 19, 2026 (GLOBE NEWSWIRE) -- Journey Medical Corporation (Nasdaq: DERM) (“Journey Medical,” “the Company,” “we” or “our”), a commercial-stage pharmaceutical company focused on developing, selling and marketing FDA-approved prescription pharmaceutical products for the treatment of dermatological conditions, today announced that Claude Maraoui, Co-Founder, President and Chief Executive Officer, will participate in a fireside chat at A.G.P.’s Annual Virtual Healthcare Conference, taking place on Wednesday, May 20, 2026. The fireside chat is scheduled to begin at 5:00pm ET.</p> <p align="justify">To register for the conference, visit the <a href="https://www.globenewswire.com/Tracker?data=OOnUQrpGBOdiZA_ykhEnctREvewm_M_zeH5lgXKPTJ6PdAQhDS8guIMzgc_NnIbUMRt3gX6hHHphHejGuMSpIKyvPml9N5rcL7IRjAkmbyYYd3Qse30RWlLCqWbLG7kdTCVU5HstVwDGMjZOp1ithQoGQYWJi8EFlO9W4oFM5l593bnQ6QOR3xpef6LhlwqY" rel="nofollow" target="_blank"><u>A.G.P. Registration Link</u></a>.</p> <p http://www.streetinsider.com/Globe+Newswire/Journey+Medical+Corporation+to+Participate+in+A.G.P.%E2%80%99s+Annual+Virtual+Healthcare+Conference/26522100.html Tue, 19 May 2026 16:45:00 -0400 DERM DERM FBIO http://www.streetinsider.com/Globe+Newswire/Journey+Medical+Corporation+to+Participate+in+A.G.P.%E2%80%99s+Annual+Virtual+Healthcare+Conference/26522100.html <p align="justify">SCOTTSDALE, Ariz., May 19, 2026 (GLOBE NEWSWIRE) -- Journey Medical Corporation (Nasdaq: DERM) (“Journey Medical,” “the Company,” “we” or “our”), a commercial-stage pharmaceutical company focused on developing, selling and marketing FDA-approved prescription pharmaceutical products for the treatment of dermatological conditions, today announced that Claude Maraoui, Co-Founder, President and Chief Executive Officer, will participate in a fireside chat at A.G.P.’s Annual Virtual Healthcare Conference, taking place on Wednesday, May 20, 2026. The fireside chat is scheduled to begin at 5:00pm ET.</p> <p align="justify">To register for the conference, visit the <a href="https://www.globenewswire.com/Tracker?data=OOnUQrpGBOdiZA_ykhEnctREvewm_M_zeH5lgXKPTJ6PdAQhDS8guIMzgc_NnIbUMRt3gX6hHHphHejGuMSpIKyvPml9N5rcL7IRjAkmbyYYd3Qse30RWlLCqWbLG7kdTCVU5HstVwDGMjZOp1ithQoGQYWJi8EFlO9W4oFM5l593bnQ6QOR3xpef6LhlwqY" rel="nofollow" target="_blank"><u>A.G.P. Registration Link</u></a>.</p> <p http://www.streetinsider.com/Globe+Newswire/Journey+Medical+Corporation+to+Participate+in+A.G.P.%E2%80%99s+Annual+Virtual+Healthcare+Conference/26522100.html Tue, 19 May 2026 16:45:00 -0400 DERM DERM FBIO http://www.streetinsider.com/Press+Releases/Fortress+Biotech+to+Participate+in+A.G.P.%E2%80%99s+Annual+Virtual+Healthcare+Conference/26510740.html <p align="justify">MIAMI, May 18, 2026 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (Nasdaq: FBIO) (“Fortress”), an innovative biopharmaceutical company focused on acquiring and advancing assets to enhance long-term value for shareholders through product revenue, equity holdings and dividend and royalty income, today announced that Lindsay A. Rosenwald, M.D., Chairman, President and Chief Executive Officer, will participate in a fireside chat at A.G.P.’s Annual Virtual Healthcare Conference, taking place on Wednesday, May 20, 2026. The fireside chat is scheduled to begin at 12:20pm ET.</p> <p align="justify">To register for the conference, visit the <a target="_blank" href="https://www.globenewswire.com/Tracker?data=bNFheN3FkqV2usQrXq33n1PhDbR0j80bPAcQCa0cyFrZxmIvxbdoVSjNi0rKrvIS8CWDe_BVte5mKThGo2xujWcrq105_YyPKeQ6BzX2I0uYiwSDEBowQ899rK0lQsLygtkw2eHDEqBvUPc1iB4sS-r8ixO7m6IAvvfoJizLUKDhkDWq5_o4W-if42O3PcLF" rel="nofollow" target="_blank">A.G.P. Registration Link</a>.</p> http://www.streetinsider.com/Press+Releases/Fortress+Biotech+to+Participate+in+A.G.P.%E2%80%99s+Annual+Virtual+Healthcare+Conference/26510740.html Mon, 18 May 2026 08:30:00 -0400 A.04794336 A.50200982 FBIO FBIOP O.00081842 O.10557543 O.15817168 http://www.streetinsider.com/Press+Releases/Fortress+Biotech+to+Participate+in+A.G.P.%E2%80%99s+Annual+Virtual+Healthcare+Conference/26510740.html <p align="justify">MIAMI, May 18, 2026 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (Nasdaq: FBIO) (“Fortress”), an innovative biopharmaceutical company focused on acquiring and advancing assets to enhance long-term value for shareholders through product revenue, equity holdings and dividend and royalty income, today announced that Lindsay A. Rosenwald, M.D., Chairman, President and Chief Executive Officer, will participate in a fireside chat at A.G.P.’s Annual Virtual Healthcare Conference, taking place on Wednesday, May 20, 2026. The fireside chat is scheduled to begin at 12:20pm ET.</p> <p align="justify">To register for the conference, visit the <a target="_blank" href="https://www.globenewswire.com/Tracker?data=bNFheN3FkqV2usQrXq33n1PhDbR0j80bPAcQCa0cyFrZxmIvxbdoVSjNi0rKrvIS8CWDe_BVte5mKThGo2xujWcrq105_YyPKeQ6BzX2I0uYiwSDEBowQ899rK0lQsLygtkw2eHDEqBvUPc1iB4sS-r8ixO7m6IAvvfoJizLUKDhkDWq5_o4W-if42O3PcLF" rel="nofollow" target="_blank">A.G.P. Registration Link</a>.</p> http://www.streetinsider.com/Press+Releases/Fortress+Biotech+to+Participate+in+A.G.P.%E2%80%99s+Annual+Virtual+Healthcare+Conference/26510740.html Mon, 18 May 2026 08:30:00 -0400 A.04794336 A.50200982 FBIO FBIOP O.00081842 O.10557543 O.15817168 http://www.streetinsider.com/Press+Releases/Fortress+Biotech+to+Participate+in+A.G.P.%E2%80%99s+Annual+Virtual+Healthcare+Conference/26510740.html <p align="justify">MIAMI, May 18, 2026 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (Nasdaq: FBIO) (“Fortress”), an innovative biopharmaceutical company focused on acquiring and advancing assets to enhance long-term value for shareholders through product revenue, equity holdings and dividend and royalty income, today announced that Lindsay A. Rosenwald, M.D., Chairman, President and Chief Executive Officer, will participate in a fireside chat at A.G.P.’s Annual Virtual Healthcare Conference, taking place on Wednesday, May 20, 2026. The fireside chat is scheduled to begin at 12:20pm ET.</p> <p align="justify">To register for the conference, visit the <a target="_blank" href="https://www.globenewswire.com/Tracker?data=bNFheN3FkqV2usQrXq33n1PhDbR0j80bPAcQCa0cyFrZxmIvxbdoVSjNi0rKrvIS8CWDe_BVte5mKThGo2xujWcrq105_YyPKeQ6BzX2I0uYiwSDEBowQ899rK0lQsLygtkw2eHDEqBvUPc1iB4sS-r8ixO7m6IAvvfoJizLUKDhkDWq5_o4W-if42O3PcLF" rel="nofollow" target="_blank">A.G.P. Registration Link</a>.</p> http://www.streetinsider.com/Press+Releases/Fortress+Biotech+to+Participate+in+A.G.P.%E2%80%99s+Annual+Virtual+Healthcare+Conference/26510740.html Mon, 18 May 2026 08:30:00 -0400 A.04794336 A.50200982 FBIO FBIOP O.00081842 O.10557543 O.15817168 http://www.streetinsider.com/Press+Releases/Fortress+Biotech+to+Participate+in+A.G.P.%E2%80%99s+Annual+Virtual+Healthcare+Conference/26510740.html <p align="justify">MIAMI, May 18, 2026 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (Nasdaq: FBIO) (“Fortress”), an innovative biopharmaceutical company focused on acquiring and advancing assets to enhance long-term value for shareholders through product revenue, equity holdings and dividend and royalty income, today announced that Lindsay A. Rosenwald, M.D., Chairman, President and Chief Executive Officer, will participate in a fireside chat at A.G.P.’s Annual Virtual Healthcare Conference, taking place on Wednesday, May 20, 2026. The fireside chat is scheduled to begin at 12:20pm ET.</p> <p align="justify">To register for the conference, visit the <a target="_blank" href="https://www.globenewswire.com/Tracker?data=bNFheN3FkqV2usQrXq33n1PhDbR0j80bPAcQCa0cyFrZxmIvxbdoVSjNi0rKrvIS8CWDe_BVte5mKThGo2xujWcrq105_YyPKeQ6BzX2I0uYiwSDEBowQ899rK0lQsLygtkw2eHDEqBvUPc1iB4sS-r8ixO7m6IAvvfoJizLUKDhkDWq5_o4W-if42O3PcLF" rel="nofollow" target="_blank">A.G.P. Registration Link</a>.</p> http://www.streetinsider.com/Press+Releases/Fortress+Biotech+to+Participate+in+A.G.P.%E2%80%99s+Annual+Virtual+Healthcare+Conference/26510740.html Mon, 18 May 2026 08:30:00 -0400 A.04794336 A.50200982 FBIO FBIOP O.00081842 O.10557543 O.15817168 http://www.streetinsider.com/Press+Releases/Fortress+Biotech+to+Participate+in+A.G.P.%E2%80%99s+Annual+Virtual+Healthcare+Conference/26510740.html <p align="justify">MIAMI, May 18, 2026 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (Nasdaq: FBIO) (“Fortress”), an innovative biopharmaceutical company focused on acquiring and advancing assets to enhance long-term value for shareholders through product revenue, equity holdings and dividend and royalty income, today announced that Lindsay A. Rosenwald, M.D., Chairman, President and Chief Executive Officer, will participate in a fireside chat at A.G.P.’s Annual Virtual Healthcare Conference, taking place on Wednesday, May 20, 2026. The fireside chat is scheduled to begin at 12:20pm ET.</p> <p align="justify">To register for the conference, visit the <a target="_blank" href="https://www.globenewswire.com/Tracker?data=bNFheN3FkqV2usQrXq33n1PhDbR0j80bPAcQCa0cyFrZxmIvxbdoVSjNi0rKrvIS8CWDe_BVte5mKThGo2xujWcrq105_YyPKeQ6BzX2I0uYiwSDEBowQ899rK0lQsLygtkw2eHDEqBvUPc1iB4sS-r8ixO7m6IAvvfoJizLUKDhkDWq5_o4W-if42O3PcLF" rel="nofollow" target="_blank">A.G.P. Registration Link</a>.</p> http://www.streetinsider.com/Press+Releases/Fortress+Biotech+to+Participate+in+A.G.P.%E2%80%99s+Annual+Virtual+Healthcare+Conference/26510740.html Mon, 18 May 2026 08:30:00 -0400 A.04794336 A.50200982 FBIO FBIOP O.00081842 O.10557543 O.15817168 http://www.streetinsider.com/Press+Releases/Fortress+Biotech+to+Participate+in+A.G.P.%E2%80%99s+Annual+Virtual+Healthcare+Conference/26510740.html <p align="justify">MIAMI, May 18, 2026 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (Nasdaq: FBIO) (“Fortress”), an innovative biopharmaceutical company focused on acquiring and advancing assets to enhance long-term value for shareholders through product revenue, equity holdings and dividend and royalty income, today announced that Lindsay A. Rosenwald, M.D., Chairman, President and Chief Executive Officer, will participate in a fireside chat at A.G.P.’s Annual Virtual Healthcare Conference, taking place on Wednesday, May 20, 2026. The fireside chat is scheduled to begin at 12:20pm ET.</p> <p align="justify">To register for the conference, visit the <a target="_blank" href="https://www.globenewswire.com/Tracker?data=bNFheN3FkqV2usQrXq33n1PhDbR0j80bPAcQCa0cyFrZxmIvxbdoVSjNi0rKrvIS8CWDe_BVte5mKThGo2xujWcrq105_YyPKeQ6BzX2I0uYiwSDEBowQ899rK0lQsLygtkw2eHDEqBvUPc1iB4sS-r8ixO7m6IAvvfoJizLUKDhkDWq5_o4W-if42O3PcLF" rel="nofollow" target="_blank">A.G.P. Registration Link</a>.</p> http://www.streetinsider.com/Press+Releases/Fortress+Biotech+to+Participate+in+A.G.P.%E2%80%99s+Annual+Virtual+Healthcare+Conference/26510740.html Mon, 18 May 2026 08:30:00 -0400 A.04794336 A.50200982 FBIO FBIOP O.00081842 O.10557543 O.15817168 http://www.streetinsider.com/Press+Releases/Fortress+Biotech+to+Participate+in+A.G.P.%E2%80%99s+Annual+Virtual+Healthcare+Conference/26510740.html <p align="justify">MIAMI, May 18, 2026 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (Nasdaq: FBIO) (“Fortress”), an innovative biopharmaceutical company focused on acquiring and advancing assets to enhance long-term value for shareholders through product revenue, equity holdings and dividend and royalty income, today announced that Lindsay A. Rosenwald, M.D., Chairman, President and Chief Executive Officer, will participate in a fireside chat at A.G.P.’s Annual Virtual Healthcare Conference, taking place on Wednesday, May 20, 2026. The fireside chat is scheduled to begin at 12:20pm ET.</p> <p align="justify">To register for the conference, visit the <a target="_blank" href="https://www.globenewswire.com/Tracker?data=bNFheN3FkqV2usQrXq33n1PhDbR0j80bPAcQCa0cyFrZxmIvxbdoVSjNi0rKrvIS8CWDe_BVte5mKThGo2xujWcrq105_YyPKeQ6BzX2I0uYiwSDEBowQ899rK0lQsLygtkw2eHDEqBvUPc1iB4sS-r8ixO7m6IAvvfoJizLUKDhkDWq5_o4W-if42O3PcLF" rel="nofollow" target="_blank">A.G.P. Registration Link</a>.</p> http://www.streetinsider.com/Press+Releases/Fortress+Biotech+to+Participate+in+A.G.P.%E2%80%99s+Annual+Virtual+Healthcare+Conference/26510740.html Mon, 18 May 2026 08:30:00 -0400 A.04794336 A.50200982 FBIO FBIOP O.00081842 O.10557543 O.15817168 http://www.streetinsider.com/Globe+Newswire/Fortress+Biotech+to+Participate+in+A.G.P.%E2%80%99s+Annual+Virtual+Healthcare+Conference/26510740.html <p align="justify">MIAMI, May 18, 2026 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (Nasdaq: FBIO) (“Fortress”), an innovative biopharmaceutical company focused on acquiring and advancing assets to enhance long-term value for shareholders through product revenue, equity holdings and dividend and royalty income, today announced that Lindsay A. Rosenwald, M.D., Chairman, President and Chief Executive Officer, will participate in a fireside chat at A.G.P.’s Annual Virtual Healthcare Conference, taking place on Wednesday, May 20, 2026. The fireside chat is scheduled to begin at 12:20pm ET.</p> <p align="justify">To register for the conference, visit the <a target="_blank" href="https://www.globenewswire.com/Tracker?data=bNFheN3FkqV2usQrXq33n1PhDbR0j80bPAcQCa0cyFrZxmIvxbdoVSjNi0rKrvIS8CWDe_BVte5mKThGo2xujWcrq105_YyPKeQ6BzX2I0uYiwSDEBowQ899rK0lQsLygtkw2eHDEqBvUPc1iB4sS-r8ixO7m6IAvvfoJizLUKDhkDWq5_o4W-if42O3PcLF" rel="nofollow" target="_blank">A.G.P. Registration Link</a>.</p> http://www.streetinsider.com/Globe+Newswire/Fortress+Biotech+to+Participate+in+A.G.P.%E2%80%99s+Annual+Virtual+Healthcare+Conference/26510740.html Mon, 18 May 2026 08:30:00 -0400 A.04794336 A.50200982 FBIO FBIOP O.00081842 O.10557543 O.15817168 http://www.streetinsider.com/Globe+Newswire/Fortress+Biotech+to+Participate+in+A.G.P.%E2%80%99s+Annual+Virtual+Healthcare+Conference/26510740.html <p align="justify">MIAMI, May 18, 2026 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (Nasdaq: FBIO) (“Fortress”), an innovative biopharmaceutical company focused on acquiring and advancing assets to enhance long-term value for shareholders through product revenue, equity holdings and dividend and royalty income, today announced that Lindsay A. Rosenwald, M.D., Chairman, President and Chief Executive Officer, will participate in a fireside chat at A.G.P.’s Annual Virtual Healthcare Conference, taking place on Wednesday, May 20, 2026. The fireside chat is scheduled to begin at 12:20pm ET.</p> <p align="justify">To register for the conference, visit the <a target="_blank" href="https://www.globenewswire.com/Tracker?data=bNFheN3FkqV2usQrXq33n1PhDbR0j80bPAcQCa0cyFrZxmIvxbdoVSjNi0rKrvIS8CWDe_BVte5mKThGo2xujWcrq105_YyPKeQ6BzX2I0uYiwSDEBowQ899rK0lQsLygtkw2eHDEqBvUPc1iB4sS-r8ixO7m6IAvvfoJizLUKDhkDWq5_o4W-if42O3PcLF" rel="nofollow" target="_blank">A.G.P. Registration Link</a>.</p> http://www.streetinsider.com/Globe+Newswire/Fortress+Biotech+to+Participate+in+A.G.P.%E2%80%99s+Annual+Virtual+Healthcare+Conference/26510740.html Mon, 18 May 2026 08:30:00 -0400 A.04794336 A.50200982 FBIO FBIOP O.00081842 O.10557543 O.15817168 http://www.streetinsider.com/Globe+Newswire/Fortress+Biotech+to+Participate+in+A.G.P.%E2%80%99s+Annual+Virtual+Healthcare+Conference/26510740.html <p align="justify">MIAMI, May 18, 2026 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (Nasdaq: FBIO) (“Fortress”), an innovative biopharmaceutical company focused on acquiring and advancing assets to enhance long-term value for shareholders through product revenue, equity holdings and dividend and royalty income, today announced that Lindsay A. Rosenwald, M.D., Chairman, President and Chief Executive Officer, will participate in a fireside chat at A.G.P.’s Annual Virtual Healthcare Conference, taking place on Wednesday, May 20, 2026. The fireside chat is scheduled to begin at 12:20pm ET.</p> <p align="justify">To register for the conference, visit the <a target="_blank" href="https://www.globenewswire.com/Tracker?data=bNFheN3FkqV2usQrXq33n1PhDbR0j80bPAcQCa0cyFrZxmIvxbdoVSjNi0rKrvIS8CWDe_BVte5mKThGo2xujWcrq105_YyPKeQ6BzX2I0uYiwSDEBowQ899rK0lQsLygtkw2eHDEqBvUPc1iB4sS-r8ixO7m6IAvvfoJizLUKDhkDWq5_o4W-if42O3PcLF" rel="nofollow" target="_blank">A.G.P. Registration Link</a>.</p> http://www.streetinsider.com/Globe+Newswire/Fortress+Biotech+to+Participate+in+A.G.P.%E2%80%99s+Annual+Virtual+Healthcare+Conference/26510740.html Mon, 18 May 2026 08:30:00 -0400 A.04794336 A.50200982 FBIO FBIOP O.00081842 O.10557543 O.15817168 http://www.streetinsider.com/Globe+Newswire/Fortress+Biotech+to+Participate+in+A.G.P.%E2%80%99s+Annual+Virtual+Healthcare+Conference/26510740.html <p align="justify">MIAMI, May 18, 2026 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (Nasdaq: FBIO) (“Fortress”), an innovative biopharmaceutical company focused on acquiring and advancing assets to enhance long-term value for shareholders through product revenue, equity holdings and dividend and royalty income, today announced that Lindsay A. Rosenwald, M.D., Chairman, President and Chief Executive Officer, will participate in a fireside chat at A.G.P.’s Annual Virtual Healthcare Conference, taking place on Wednesday, May 20, 2026. The fireside chat is scheduled to begin at 12:20pm ET.</p> <p align="justify">To register for the conference, visit the <a target="_blank" href="https://www.globenewswire.com/Tracker?data=bNFheN3FkqV2usQrXq33n1PhDbR0j80bPAcQCa0cyFrZxmIvxbdoVSjNi0rKrvIS8CWDe_BVte5mKThGo2xujWcrq105_YyPKeQ6BzX2I0uYiwSDEBowQ899rK0lQsLygtkw2eHDEqBvUPc1iB4sS-r8ixO7m6IAvvfoJizLUKDhkDWq5_o4W-if42O3PcLF" rel="nofollow" target="_blank">A.G.P. Registration Link</a>.</p> http://www.streetinsider.com/Globe+Newswire/Fortress+Biotech+to+Participate+in+A.G.P.%E2%80%99s+Annual+Virtual+Healthcare+Conference/26510740.html Mon, 18 May 2026 08:30:00 -0400 A.04794336 A.50200982 FBIO FBIOP O.00081842 O.10557543 O.15817168 http://www.streetinsider.com/Globe+Newswire/Fortress+Biotech+to+Participate+in+A.G.P.%E2%80%99s+Annual+Virtual+Healthcare+Conference/26510740.html <p align="justify">MIAMI, May 18, 2026 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (Nasdaq: FBIO) (“Fortress”), an innovative biopharmaceutical company focused on acquiring and advancing assets to enhance long-term value for shareholders through product revenue, equity holdings and dividend and royalty income, today announced that Lindsay A. Rosenwald, M.D., Chairman, President and Chief Executive Officer, will participate in a fireside chat at A.G.P.’s Annual Virtual Healthcare Conference, taking place on Wednesday, May 20, 2026. The fireside chat is scheduled to begin at 12:20pm ET.</p> <p align="justify">To register for the conference, visit the <a target="_blank" href="https://www.globenewswire.com/Tracker?data=bNFheN3FkqV2usQrXq33n1PhDbR0j80bPAcQCa0cyFrZxmIvxbdoVSjNi0rKrvIS8CWDe_BVte5mKThGo2xujWcrq105_YyPKeQ6BzX2I0uYiwSDEBowQ899rK0lQsLygtkw2eHDEqBvUPc1iB4sS-r8ixO7m6IAvvfoJizLUKDhkDWq5_o4W-if42O3PcLF" rel="nofollow" target="_blank">A.G.P. Registration Link</a>.</p> http://www.streetinsider.com/Globe+Newswire/Fortress+Biotech+to+Participate+in+A.G.P.%E2%80%99s+Annual+Virtual+Healthcare+Conference/26510740.html Mon, 18 May 2026 08:30:00 -0400 A.04794336 A.50200982 FBIO FBIOP O.00081842 O.10557543 O.15817168 http://www.streetinsider.com/Globe+Newswire/Fortress+Biotech+to+Participate+in+A.G.P.%E2%80%99s+Annual+Virtual+Healthcare+Conference/26510740.html <p align="justify">MIAMI, May 18, 2026 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (Nasdaq: FBIO) (“Fortress”), an innovative biopharmaceutical company focused on acquiring and advancing assets to enhance long-term value for shareholders through product revenue, equity holdings and dividend and royalty income, today announced that Lindsay A. Rosenwald, M.D., Chairman, President and Chief Executive Officer, will participate in a fireside chat at A.G.P.’s Annual Virtual Healthcare Conference, taking place on Wednesday, May 20, 2026. The fireside chat is scheduled to begin at 12:20pm ET.</p> <p align="justify">To register for the conference, visit the <a target="_blank" href="https://www.globenewswire.com/Tracker?data=bNFheN3FkqV2usQrXq33n1PhDbR0j80bPAcQCa0cyFrZxmIvxbdoVSjNi0rKrvIS8CWDe_BVte5mKThGo2xujWcrq105_YyPKeQ6BzX2I0uYiwSDEBowQ899rK0lQsLygtkw2eHDEqBvUPc1iB4sS-r8ixO7m6IAvvfoJizLUKDhkDWq5_o4W-if42O3PcLF" rel="nofollow" target="_blank">A.G.P. Registration Link</a>.</p> http://www.streetinsider.com/Globe+Newswire/Fortress+Biotech+to+Participate+in+A.G.P.%E2%80%99s+Annual+Virtual+Healthcare+Conference/26510740.html Mon, 18 May 2026 08:30:00 -0400 A.04794336 A.50200982 FBIO FBIOP O.00081842 O.10557543 O.15817168 http://www.streetinsider.com/Globe+Newswire/Fortress+Biotech+to+Participate+in+A.G.P.%E2%80%99s+Annual+Virtual+Healthcare+Conference/26510740.html <p align="justify">MIAMI, May 18, 2026 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (Nasdaq: FBIO) (“Fortress”), an innovative biopharmaceutical company focused on acquiring and advancing assets to enhance long-term value for shareholders through product revenue, equity holdings and dividend and royalty income, today announced that Lindsay A. Rosenwald, M.D., Chairman, President and Chief Executive Officer, will participate in a fireside chat at A.G.P.’s Annual Virtual Healthcare Conference, taking place on Wednesday, May 20, 2026. The fireside chat is scheduled to begin at 12:20pm ET.</p> <p align="justify">To register for the conference, visit the <a target="_blank" href="https://www.globenewswire.com/Tracker?data=bNFheN3FkqV2usQrXq33n1PhDbR0j80bPAcQCa0cyFrZxmIvxbdoVSjNi0rKrvIS8CWDe_BVte5mKThGo2xujWcrq105_YyPKeQ6BzX2I0uYiwSDEBowQ899rK0lQsLygtkw2eHDEqBvUPc1iB4sS-r8ixO7m6IAvvfoJizLUKDhkDWq5_o4W-if42O3PcLF" rel="nofollow" target="_blank">A.G.P. Registration Link</a>.</p> http://www.streetinsider.com/Globe+Newswire/Fortress+Biotech+to+Participate+in+A.G.P.%E2%80%99s+Annual+Virtual+Healthcare+Conference/26510740.html Mon, 18 May 2026 08:30:00 -0400 A.04794336 A.50200982 FBIO FBIOP O.00081842 O.10557543 O.15817168 http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++Fortress+Biotech%2C+Inc.+++++++++++++++++Filed+by%3A+HIGHBRIDGE+CAPITAL+MANAGEMENT+LLC/26498827.html si-local-file:///var/storage/secattach/20260515/26498827.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++Fortress+Biotech%2C+Inc.+++++++++++++++++Filed+by%3A+HIGHBRIDGE+CAPITAL+MANAGEMENT+LLC/26498827.html Fri, 15 May 2026 06:20:00 -0400 FBIO O.15817168 http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++Fortress+Biotech%2C+Inc.+++++++++++++++++Filed+by%3A+HIGHBRIDGE+CAPITAL+MANAGEMENT+LLC/26498827.html si-local-file:///var/storage/secattach/20260515/26498827.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++Fortress+Biotech%2C+Inc.+++++++++++++++++Filed+by%3A+HIGHBRIDGE+CAPITAL+MANAGEMENT+LLC/26498827.html Fri, 15 May 2026 06:20:00 -0400 FBIO O.15817168 http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++Fortress+Biotech%2C+Inc.++++For%3A+Mar+31/26495771.html si-local-file:///var/storage/secattach/20260514/26495771.html http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++Fortress+Biotech%2C+Inc.++++For%3A+Mar+31/26495771.html Thu, 14 May 2026 16:32:00 -0400 FBIO O.15817168 http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++Fortress+Biotech%2C+Inc.++++For%3A+Mar+31/26495771.html si-local-file:///var/storage/secattach/20260514/26495771.html http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++Fortress+Biotech%2C+Inc.++++For%3A+Mar+31/26495771.html Thu, 14 May 2026 16:32:00 -0400 FBIO O.15817168 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Fortress+Biotech%2C+Inc.++++For%3A+May+14/26495459.html si-local-file:///var/storage/secattach/20260514/26495459.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Fortress+Biotech%2C+Inc.++++For%3A+May+14/26495459.html Thu, 14 May 2026 16:23:00 -0400 FBIO O.15817168